Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Product Information [Line Items]
Revenues	$ 4,257,767	$ 4,602,353
Accounts Receivable, after Allowance for Credit Loss	5,978,764		$ 6,406,555
Sale from customer	705,500		880,500
Allowance for doubtful accounts	166,901		119,791
Loss on impairment of goodwill			218,308
Advertising expenses	109,000	93,000
Stock-based compensation expenses	467,517	$ 677,507
Change in fair value of contingent consideration	514,333
Contingent consideration	$ 4,356,467		$ 4,870,800
Convertible Notes Payable [Member]
Product Information [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,664,366	0
Cashless Warrants [Member]
Product Information [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	14,225,000	1,000,000
Healthcare Insurers [Member]
Product Information [Line Items]
Revenues	$ 1,620,281
Healthcare Insurers And Government Payers [Member]
Product Information [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 3,124,432
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Healthcare Insurers And Government Payers [Member]
Product Information [Line Items]
Concentrations of credit risk	38.00%